EP1319409A4 — SOLID PREPARATIONS
Assigned to Takeda Pharmaceutical Co Ltd · Expires 2006-05-03 · 20y expired
What this patent protects
It is intended to provide granules containing a large amount of a physiologically active substance which is hardly soluble in water and highly water-repellent, and solid preparations containing these granules which are excellent in the disintegration properties and the elution of…
USPTO Abstract
It is intended to provide granules containing a large amount of a physiologically active substance which is hardly soluble in water and highly water-repellent, and solid preparations containing these granules which are excellent in the disintegration properties and the elution of the physiologically active substance. Namely, (1) granules containing a physiologically active substance and a cellulose-based disintegrating agent; (2) granules containing a physiologically active substance, a cellulose-based disintegrating agent and a binder; (3) solid preparations comprising granules (1) or (2) as described above, a cellulose-based disintegrating agent and a stearic acid-based lubricant; and (4) the solid preparations (3) as described above which are shaped into ellipsoidal tablets.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.